Eleventh-Hour Human Factors Testing May Slow Product Review at FDA
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers that delay human factors testing until late in the product development cycle likely will face greater FDA scrutiny during premarket evaluation, according to agency reviewers speaking April 29 at a Food & Drug Law Institute videoconference.